Published in Surg Today on June 16, 2012
TransAnal Minimally Invasive Surgery (TAMIS) with SILS™ port versus Transanal Endoscopic Microsurgery (TEM): a comparative experimental study. Surg Endosc (2013) 2.19
A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech Coloproctol (2014) 1.34
What is the best tool for transanal endoscopic microsurgery (TEM)? A case-matched study in 74 patients comparing a standard platform and a disposable material. Int J Colorectal Dis (2016) 0.79
Significance of defect closure following transanal local full-thickness excision of rectal malignant tumors. Mol Clin Oncol (2016) 0.75
Transanal minimally invasive surgery (TAMIS) with a GelPOINT(®) Path for lower rectal cancer as an alternative to transanal endoscopic microsurgery (TEM). Mol Clin Oncol (2016) 0.75
Transanal minimally invasive surgery: a giant leap forward. Surg Endosc (2010) 2.93
Single-incision laparoscopic cholecystectomy: initial evaluation of a large series of patients. Surg Endosc (2009) 1.90
Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg (2007) 1.66
Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum (2005) 1.61
Anorectal sphincter function and rectal barostat study in patients following transanal endoscopic microsurgery. Int J Colorectal Dis (2001) 1.25
Single incision laparoscopic right colectomy. Surg Endosc (2010) 1.14
[Transanal endoscopic microsurgery]. Leber Magen Darm (1985) 1.10
Cost analysis of transanal endoscopic microsurgery for rectal tumours. Colorectal Dis (2007) 1.08
Transanal endoscopic microsurgery excision: is anorectal function compromised? Dis Colon Rectum (2002) 1.06
Transanal single port microsurgery (TSPM) as a modified technique of transanal endoscopic microsurgery (TEM). Surg Innov (2010) 1.04
Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc (2008) 1.00
Long-term results of laparoscopic colorectal cancer resection: current knowledge and what remains unclear. Surg Today (2010) 0.87
Transanal endoscopic microsurgery: a single surgeon's experience. Arch Surg (1998) 0.82
Transanal endoscopic microsurgery for rectal tumors: experience at Korea's National Cancer Center. Surg Endosc (2009) 0.80
[Comparison of radical retropubic prostatectomy under combined lumbar spinal and epidural anesthesia with that under combined general and epidural anesthesia]. Nihon Hinyokika Gakkai Zasshi (2005) 0.77
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol (2012) 2.77
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol (2013) 1.72
Acute Appendicitis in an Incarcerated Femoral Hernia: A Case of De Garengeot Hernia. Case Rep Gastroenterol (2009) 1.67
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol (2003) 1.50
Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg (2011) 1.50
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation. J Surg Res (2012) 1.41
Tetra-chlorido[(diphenyl-phosphino)diphenyl-phosphine oxide-κO]zirconium(IV) benzene monosolvate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.41
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J Immunol (2007) 1.40
Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices. Digestion (2004) 1.39
Rembrandt's Bathsheba, possible lactation mastitis following unsuccessful pregnancy. Med Hypotheses (2006) 1.37
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery (2005) 1.32
Outcomes after emergency surgery for gastric perforation or severe bleeding in patients with gastric cancer. J Surg Oncol (2002) 1.31
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer (2000) 1.21
Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg (2002) 1.19
Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol (2005) 1.17
Nucleobase Stacking Evidenced on Ternary Metal (Palladium(II), Copper(II)) Complexes with Nucleobase Amino Acids and Aromatic Diimines. Inorg Chem (1999) 1.16
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology (2002) 1.16
Neural correlates of psychotic symptoms in dementia with Lewy bodies. Brain (2009) 1.13
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Pringle's manoeuvre in living donors. Lancet (2002) 1.08
Collision tumor of the stomach: a rare case of an adenocarcinoma and carcinoid tumor. Arch Pathol Lab Med (2005) 1.07
Successful surgical treatment for an aortoesophageal fistula due to a descending aortic aneurysm. Ann Thorac Cardiovasc Surg (2003) 1.07
Mortality for gastric cancer in elderly patients. J Surg Oncol (2003) 1.05
Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol (2003) 1.05
Incidence of bile leakage after three types of hepatic parenchymal transection. Hepatogastroenterology (2003) 1.05
Construction of a square-planar hydroperoxo-copper(II) complex inducing a higher catalytic reactivity. Chem Commun (Camb) (2003) 1.04
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest (2010) 1.04
Identification of potent odorants in different green tea varieties using flavor dilution technique. J Agric Food Chem (2002) 1.03
Reactivity of hydroperoxide bound to a mononuclear non-heme iron site. Inorg Chem (2002) 1.02
p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res (2004) 1.01
Recent advances in chemotherapy for advanced gastric cancer in Japan. Surg Today (2010) 1.00
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology (2006) 1.00
Right lateral sector graft in adult living-related liver transplantation. Transplantation (2002) 1.00
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide. Cancer Sci (2009) 1.00
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation (2004) 0.99
Steric and hydrogen-bonding effects on the stability of copper complexes with small molecules. Inorg Chem (2004) 0.98
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci (2013) 0.98
Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities. Clin Immunol (2005) 0.98
Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol (2003) 0.97
An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res (2002) 0.97
FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology (2004) 0.97
Isolated tuberculous liver abscess invading the abdominal wall: report of a case. Surg Today (2011) 0.97
Suppression of melanin production by expression of HSP70. J Biol Chem (2010) 0.96
Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res (2003) 0.95
Antiallergic effect of flavonoid glycosides obtained from Mentha piperita L. Biol Pharm Bull (2002) 0.95
Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol (2007) 0.95
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Factor structure of a modified version of the wisconsin card sorting test: an analysis of executive deficit in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2003) 0.94
Progress in surgical treatment of hepatocellular carcinoma. Oncology (2002) 0.93
Safe donor hepatectomy for living related liver transplantation. Liver Transpl (2002) 0.93
Current approaches to the treatment of early hepatocellular carcinoma. Oncologist (2010) 0.93
Clinical significance of early hepatocellular carcinoma. Liver Transpl (2004) 0.93
Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells. J Thorac Cardiovasc Surg (2005) 0.92
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology (2014) 0.92
Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PLoS One (2012) 0.92
Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg (2008) 0.92
D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol (2014) 0.92
Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol (2006) 0.91
Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. Psychosomatics (2002) 0.90
Endovascular stenting for celiac axis stenosis before pancreaticoduodenectomy. Surgery (2003) 0.89
Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol (2005) 0.89
Copper hydroperoxo species activated by hydrogen-bonding interaction with its distal oxygen. Inorg Chem (2003) 0.89
Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantation. Transplantation (2002) 0.89
Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg (2008) 0.89
Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. Cancer Chemother Pharmacol (2007) 0.88
Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with cisplatin: a case report. Anticancer Res (2011) 0.88
Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen. Transplantation (2005) 0.88
Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology (2002) 0.88
Caudate lobectomy (segmentectomy 1) (with video). J Hepatobiliary Pancreat Sci (2012) 0.87
Gastrointestinal bleeding after living-related liver transplantation. Dig Dis Sci (2002) 0.87
Staged approach to the urachal cyst with infected omphalitis. Int Surg (2006) 0.87
Highly ordered anodic porous alumina with 13-nm hole intervals using a 2D array of monodisperse nanoparticles as a template. Small (2006) 0.87
Preoperative portal embolization in patients with hepatocellular carcinoma. World J Surg (2001) 0.87
Structural and spectroscopic features of a cis (hydroxo)-Fe(III)-(carboxylato) configuration as an active site model for lipoxygenases. Inorg Chem (2002) 0.87
Characteristics of ectopic pancreas in dynamic gadolinium-enhanced MRI. Abdom Imaging (2008) 0.86
Exophytic primary squamous cell carcinoma of the stomach. J Gastroenterol (2004) 0.86
Validation of perioperative steroids administration in liver resection: a randomized controlled trial. Ann Surg (2011) 0.86
Characterization of antireflection moth-eye film on crystalline silicon photovoltaic module. Opt Express (2011) 0.86
Irinotecan plus S-1 for liver metastases of gastric cancer. Hepatogastroenterology (2010) 0.85
Measurement of extra-pancreatic secretory function by 13C-dipeptide breath test. Transl Res (2007) 0.85